Rachel Brazil is a science writer based in London, UK
Photopharmacology: using light to activate drugsSubscription
Drugs that contain synthetic light-switching molecules could help target therapies to particular parts of the body, limiting side effects. Researchers have started using this approach to tackle blindness, cancer, diabetes, and antibiotic resistance, but questions remain about the clinical practicality of the field.
In a world where technology and social media allow individuals to gather information and network online for free, professional associations are evolving and changing their offering to members in order to stay relevant.